Regulation FD Disclosure - Form 8-K

Item 7.01 Regulation FD Disclosure.

Nuo Therapeutics, Inc. (the "Company") will not file its Annual Report on Form 10-K by April 16, 2024, as previously expected and as reported on its recently filed Form 12b-25. The principal reason for the delay in filing is to allow the Company's independent registered public accounting firm to complete and finalize its review of the Company's audited financial statements for the year ended December 31, 2023. The Company believes the review will be finalized shortly and expects the Form 10-K to be filed no later than April 19, 2024.

Forward-Looking Statements

This Form 8-K contains forward-looking statements, which are based on management's current expectations or beliefs about the Company's future plans, expectations, and objectives. These forward-looking statements are not historical facts and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in or implied by these forward-looking statements including, including statements regarding the Company's intention to file the Form 10-K by April 19, 2024. Readers of this Form 8-K are cautioned not to place undue reliance on forward-looking statements contained herein, which speak only as of the date of this Form 8-K.